These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12904528)

  • 1. Memantine in moderate-to-severe Alzheimer's disease.
    Bleich S; Wiltfang J; Kornhuber J
    N Engl J Med; 2003 Aug; 349(6):609-10; author reply 609-10. PubMed ID: 12904528
    [No Abstract]   [Full Text] [Related]  

  • 2. Memantine in moderate-to-severe Alzheimer's disease.
    Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ;
    N Engl J Med; 2003 Apr; 348(14):1333-41. PubMed ID: 12672860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ
    Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
    MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves memantine drug for treating AD.
    Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug for moderate to advanced Alzheimer's approved.
    Mayo Clin Health Lett; 2004 Feb; 22(2):4. PubMed ID: 15032170
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.
    Bassil N; Thaipisuttikul P; Grossberg GT
    Expert Opin Pharmacother; 2010 Jul; 11(10):1765-71. PubMed ID: 20540654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine for dementia?
    Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D; Andersen HF
    Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical relevance of memantine use].
    Sobów T
    Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 15. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT; Pejović V; Miller ML; Graham SM
    Dement Geriatr Cogn Disord; 2009; 27(2):164-72. PubMed ID: 19194105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL; Lladó Plarrumaní A
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
    Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
    Mecocci P; Bladström A; Stender K
    Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.